
Join to view full profile
1555 N. Barrington Rd.Building 3, Suite 1200Hoffman Estates, IL 60169
Phone+1 847-885-4100
Fax+1 847-885-4199
Dr. Tajuddin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alkarim Tajuddin is an oncology specialist based in Elk Grove Village, IL, affiliated with Northwest Oncology & Hematology SC since 1996. He completed his fellowship in Hematology and Medical Oncology at McGaw Medical Center of Northwestern University and holds an MBA from DePaul. His expertise includes hematologic oncology, breast cancer, chronic neutrophilic leukemia, and bronchial cancer. Dr. Tajuddin contributed to the field with his publication on hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy, cited 115 times. He has been involved in clinical trials focusing on treatments for invasive breast cancer and preventive methods for lymphedema. He also garnered recognition with the CMS Meaningful Use Stage 1 Certification from OncoEMR in 2011-2013.
Education & Training
DePaulMBA, 2001 - 2004
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1993 - 1996
Wright State UniversityResidency, Internal Medicine, 1990 - 1993
Dow University of Health SciencesClass of 1987
Certifications & Licensure
IL State Medical License 1993 - 2029
IA State Medical License 1991 - 1995
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Flatiron Health, Inc., 2011, 2013-2017
Clinical Trials
- Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
Publications & Presentations
PubMed
- 117 citationsHand-foot syndrome associated with liposome-encapsulated doxorubicin therapyKenneth B. Gordon, Alkarim Tajuddin, Joan Guitart, Timothy M. Kuzel, Lynne R. Eramo
Cancer. 1995-04-15
Committees
- Chair, Medicine Quality 2016 - 2026
- Chair, Blood utilization committee 2015 - 2026
Other Languages
- Urdu, Gujarati, Hindi
External Links
- Northwestoncology and hematologyhttps://www.northwestoncology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









